Relation of <i>JAK2</i> V617F allele burden and coronary calcium score in patients with essential thrombocythemia

The average <i>JAK2</i> allele burden decreased in our patients with high-risk ET during the four-year period. However, in the small subgroup whose <i>JAK2</i> mutation burden increased the Agatston coronary calcium score increased as well. This finding, which should be interpreted with caution and validated in a larger group, is in line with emerging evidence that <i>JAK2</i> mutation accelerates atherosclerosis and can be regarded as a non-classical risk factor for cardiovascular disease.

Authors

Institutions

Publication Details

Journal
Radiology and Oncology
Published
2024-10-04
DOI
https://doi.org/10.2478/raon-2024-0036
Citations
2
Primary Topic
Myeloproliferative Neoplasms: Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.88

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Relation of JAK2 V617F allele burden and coronary calcium score in patients with essential thrombocythemia

Tadej Pajič, Ajda Anžič Drofenik, Mojca Božič Mijovski, Aleš Blinc et al.
2 citations
Radiology and Oncology
Myeloproliferative Neoplasms: Diagnosis and Treatment
0.88
article

Relation of JAK2 V617F allele burden and coronary calcium score in patients with essential thrombocythemia

Tadej Pajič, Ajda Anžič Drofenik, Mojca Božič Mijovski, Aleš Blinc, Matjaž Sever, Matjaž Vrtovec
article en
2 citations

Abstract

The average <i>JAK2</i> allele burden decreased in our patients with high-risk ET during the four-year period. However, in the small subgroup whose <i>JAK2</i> mutation burden increased the Agatston coronary calcium score increased as well. This finding, which should be interpreted with caution and validated in a larger group, is in line with emerging evidence that <i>JAK2</i> mutation accelerates atherosclerosis and can be regarded as a non-classical risk factor for cardiovascular disease.

Radiology and OncologyVol. 58(4)
University of Ljubljana (SI), Ljubljana University Medical Centre (SI), University of Maribor (SI)
Javna Agencija za Raziskovalno Dejavnost RS
Good health and well-being
Openalex Percentile: Top 24%
Myeloproliferative Neoplasms: Diagnosis and Treatment
0.88
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.